Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

708
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
708
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

1.5K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.5K
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

648
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
648

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Caffeine as a Viscosity-Reducing Agent for High-Concentration mAb Formulations: Insights from Molecular Dynamics Simulations.

The journal of physical chemistry. B·2026
Same author

Predicting Distribution Coefficients (LogD) of Cyclic Peptides Using Molecular Dynamics Simulations.

Pharmaceutical research·2025
Same author

Coarse-Grained Molecular Dynamics Simulation of Heterogeneous Polysorbate 80 Surfactants and their Interactions with Small Molecules and Proteins.

Molecular pharmaceutics·2024
Same author

Molecular Dynamics Simulation of an Iron(III) Binding Site on the Fc Domain of IgG1 Relevant for Visible Light-Induced Protein Fragmentation.

Molecular pharmaceutics·2023
Same author

Emerging Process Modeling Capabilities for Dry Powder Operations for Inhaled Formulations.

Molecular pharmaceutics·2023
Same author

Development of an In Vitro System To Emulate an In Vivo Subcutaneous Environment: Small Molecule Drug Assessment.

Molecular pharmaceutics·2022

相关实验视频

Updated: Jan 14, 2026

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

890

开发皮下配方,以将虹膜素作为潜在的治疗药物.

Gang Hu1,2, Xi Luan1, Michael J Hageman1,2

  • 1Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS, 66047, USA.

Pharmaceutical research
|October 22, 2025
PubMed
概括

研究人员为潜在的肥胖疗法开发了稳定的皮下虹膜素配方. 这些配方保留了色素.

关键词:
虹膜是一种虹膜.溶解化 溶解化是一种肥胖 肥胖 肥胖 肥胖 肥胖 肥胖 肥胖 肥胖稳定的稳定性 稳定的稳定性用于皮下注射的配方.

更多相关视频

Development, Characterization, and Evaluation of CAGE-based Ionic Liquid Systems for Transdermal Delivery
09:44

Development, Characterization, and Evaluation of CAGE-based Ionic Liquid Systems for Transdermal Delivery

Published on: September 26, 2025

430
Development of a Refined Protocol for Trans-scleral Subretinal Transplantation of Human Retinal Pigment Epithelial Cells into Rat Eyes
12:45

Development of a Refined Protocol for Trans-scleral Subretinal Transplantation of Human Retinal Pigment Epithelial Cells into Rat Eyes

Published on: August 12, 2017

10.0K

相关实验视频

Last Updated: Jan 14, 2026

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

890
Development, Characterization, and Evaluation of CAGE-based Ionic Liquid Systems for Transdermal Delivery
09:44

Development, Characterization, and Evaluation of CAGE-based Ionic Liquid Systems for Transdermal Delivery

Published on: September 26, 2025

430
Development of a Refined Protocol for Trans-scleral Subretinal Transplantation of Human Retinal Pigment Epithelial Cells into Rat Eyes
12:45

Development of a Refined Protocol for Trans-scleral Subretinal Transplantation of Human Retinal Pigment Epithelial Cells into Rat Eyes

Published on: August 12, 2017

10.0K

科学领域:

  • 生物化学 生物化学
  • 药理学 药理学是指药理学的学科.
  • 内分泌学 在内分泌学.

背景情况:

  • 在运动期间释放的一种肌素 - - 虹膜素 (Irisin) 显示出潜在的治疗效益.
  • 药物开发的伊丽是由有限的表征和配方研究阻碍.

研究的目的:

  • 开发适用于制药应用的皮下素配方.
  • 鉴定素的特征并评估其生物活性.

主要方法:

  • 在大肠杆菌中表达虹膜蛋白,使用生物物理技术进行净化和表征.
  • 评估素的生物活性,特别是脂肪细胞色诱导.
  • 对皮下配方的pH,辅料和格式 (溶解或水性) 的选.
  • 在各种存储条件下研究配方稳定性.

主要成果:

  • 成功地提取和净化可溶性和重新折叠的虹膜素,具有可比的生物物理特性和生物活性.
  • 开发了使用酸盐缓冲剂 (pH 7),糖/三糖和聚酸盐80的稳定冷解化素配方.
  • 配方表现出快速溶解,保留了化后的虹膜素特性和生物活性,并在40°C/75%RH下稳定一个月.

结论:

  • 已建立稳定的皮下虹膜素配方,适合制药开发.
  • 这些配方为针对肥胖和相关代谢障碍的以虹素为基础的疗法提供了基础.